The Founder's Guide to

Persephoni BioPartners

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Founded by Hilary Schultz, Persephoni BioPartners is a biotechnology venture studio located in the United States. The firm specializes in partnering with innovators at the earliest stages to develop therapeutics from scientific breakthroughs. They focus on building high-impact biotech companies and currently manage a portfolio of four companies.

Learn More

Frequently Asked Questions

Does Persephoni BioPartners lead rounds?

Yes, Persephoni BioPartners often leads investment rounds in the companies they partner with, particularly in the pre-seed and seed stages.

What is Persephoni BioPartners' stance on follow-on investments?

The firm is open to follow-on investments, especially for companies that demonstrate strong progress and potential for clinical relevance.

How large is Persephoni BioPartners' current fund?

Specific fund size details are not disclosed, but the firm focuses on early-stage investments in biotech.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.